| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Ethics |
Division of Medical Ethics, Weill Medical College of Cornell University, New York, USA
Key Words. HPV • Cervical cancer • Ethics • Justice
Correspondence: Inmaculada de Melo-Martín, Ph.D., M.S., Division of Medical Ethics, Weill Medical College of Cornell University, 411 East 69th Street, New York, NY 10021, USA. Telephone: 212-746-1268; Fax: 212-746-8544; e-mail: imd2001{at}med.cornell.edu
The recent announcement of an experimental vaccine against human papillomavirus (HPV) has raised great hopes and expectations. Promising trial results, however, should not obscure ethical issues related to a vaccines ultimate dissemination. Although lay media might view an HPV vaccine as a panacea, a more complicated ethical reality exists, touching upon public knowledge, health care disparities, and parental consent for childhood vaccination.
This article has been cited by other articles:
![]() |
Minerva BMJ, May 6, 2006; 332(7549): 1102 - 1102. [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |